Labshake search
Citations for Tocris :
1 - 24 of 24 citations for Scyliorhinin II amide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... PKI14,22 amide (Tocris) 1μM ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 µM PKA inhibitor fragment (6-22) amide (Tocris Bioscience), 0.5 mM anisomycin (stock solution in EtOH ...
-
bioRxiv - Biochemistry 2024Quote: ... Exendin-3 (9-39) amide (2081) was purchased from Tocris. Recombinant GDF15 (957-GD ...
-
bioRxiv - Cell Biology 2020Quote: PKA inhibitor (PKI) fragment (6-22) amide was purchased from Tocris (Cat. No. 1904). Full length mouse PKIα was synthesized from L amino acids and then purified with High-performance liquid chromatography (HPLC ...
-
bioRxiv - Physiology 2024Quote: ... 4-(3-chloro-pyridin-2-yl)-piperazine-1-carboxylic acid (4-tert-butyl-phenyl)-amide (BCTC, Tocris #3875) 10 mM in DMSO ...
-
bioRxiv - Neuroscience 2021Quote: ... n=20) group were randomized to receive either saline or GLP-1R antagonist Exendin-3(9-39)amide (Ex-9) (Tocris Bioscience, UK) (85 μg/kg dissolved in saline ...
-
bioRxiv - Neuroscience 2019Quote: ... LY341495 (group II mGluR; Tocris), MK-801 (NMDA receptors ...
-
bioRxiv - Neuroscience 2020Quote: ... angiotensin II (Tocris, Bristol, UK), or human ACE2 (R&D ...
-
bioRxiv - Cell Biology 2021Quote: ... and 30 µM SKI-II (Tocris). All inhibitors were dissolved in DMSO and diluted to 10x concentration in OptiMEM ...
-
bioRxiv - Molecular Biology 2023Quote: ... Ang II (4474-91-3, Tocris) was injected subcutaneously at a total dose of 1 ...
-
bioRxiv - Developmental Biology 2020Quote: ... and TGFβ Receptor I Inhibitor II (25nM; Tocris were also used in this study ...
-
bioRxiv - Neuroscience 2021Quote: ... [DAla2]-Deltorphin II and SDM25H HCl (Tocris, Minneapolis, MN), [Met5]enkephalin (Genscript ...
-
bioRxiv - Cancer Biology 2020Quote: KN-93 phosphate (CAMK II inhibitor) was obtained from Tocris Bioscience (Bristol ...
-
bioRxiv - Bioengineering 2022Quote: ... Ang II (Auspep, Tullamarine, Australia) and valsartan (Tocris Bioscience, Bristol, UK): 100 nL of 1 mmol/L in PBS at 0.1 µL/min ...
-
bioRxiv - Neuroscience 2023Quote: ... Melanotan II (i.e., MTII, MC3R/MC4R agonist, Tocris, 25661, Batch 6A) was dissolved in saline at 0.5 μg/μl and used for i.p ...
-
bioRxiv - Neuroscience 2023Quote: ... the group-II mGluR agonist DCG-IV (2µM) (Tocris: 0975/1) was bath applied for 5-10 mins at the end of experiments with mossy fibre stimulation 27 ...
-
bioRxiv - Cell Biology 2020Quote: ... The skeletal muscle myosin II inhibitor N-benzyl-p-toluene sulphonamide (BTS, Tocris 1870) was added to fiber dishes at a concentration of 15 μM to reduce Ca2+ induced contraction after plasma membrane injury ...
-
bioRxiv - Biophysics 2023Quote: The following pharmacological inhibitors and chemical compounds were used: Blebbistatin (Myosin II inhibitor Tocris™) at a final concentration of 100 µM ...
-
bioRxiv - Microbiology 2022Quote: ... E64d and MMP-2/MMP-9 Inhibitor II were from MilliporeSigma and TAPI-2 from Tocris.
-
bioRxiv - Neuroscience 2020Quote: ... we utilized another widely used group II mGluR agonist LY379268 (Tocris, product 2453; Monn et al., 1999). Both compounds were prepared in sterile water and pH increased to 8.5 using 1 N NaOH ...
-
bioRxiv - Physiology 2023Quote: ... injections of either vehicle (PBS) or the α-MSH analogue melanotan-II (0.3 mg/kg/day, Tocris, # 2566).16 Sham-operated mice received vehicle according to the same treatment scheme ...
-
bioRxiv - Neuroscience 2021Quote: ... an agonist of group II metabotropic glutamate receptors (mGluR2/3) that reduces release probability in mossy fiber terminals (1 μM, Tocris)(Kamiya et al. ...
-
bioRxiv - Cell Biology 2021Quote: Receptors were stimulated as follows: human Angiotensin 1 receptor (AT1R) with Angiotensin II (AngII; Tocris 4474-91-3, in measuring buffer), human β2 adrenergic receptor (β2ADR ...
-
bioRxiv - Neuroscience 2021Quote: ... namely the mitogen activated protein kinase kinase (MAPKK) inhibitor U0126 (50 μM) and the CaM kinase II (CaMKII) inhibitor KN-62 (10 μM) (Tocris Bioscience, United Kingdom). The inhibitors were added to the cultures thirty minutes prior to DOI treatment ...